[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.27.4″ custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text admin_label=”Text” _builder_version=”4.27.4″ text_font_size=”16px” text_line_height=”1.9em” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||||false|false” custom_margin_tablet=”|||-32px|false|false” custom_margin_phone=”|||-32px|false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
Montreal, June 4, 2024 \u2013 ISOLOGIC Innovative Radiopharmaceuticals is investing $29,9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as part of Quebec\u2019s life sciences ecosystem.<\/span><\/p>\n Approximately $19 million will be devoted to the expansion and modernization of the Lachine borough site, and $11 million will be used to purchase state of the art equipment which includes a 18 MeV cyclotron which will be operational from the first quarter of 2026. This investment will help add redundancy to the supply chain and meet the growing demand for critically important PET diagnostic radioisotopes in both Quebec and across Canada.<\/span><\/p>\n Read the press release for more info\u00a0<\/span>here<\/a><\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Montreal, June 4, 2024 \u2013 ISOLOGIC Innovative Radiopharmaceuticals is investing $29,9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as part of Quebec\u2019s life sciences ecosystem. Approximately $19 million will be devoted to the expansion […]<\/p>\n","protected":false},"author":1,"featured_media":3011,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"Montr\u00e9al, le 4 juin 2024<\/strong> \u2013 ISOLOGIC Radiopharmaceutiques Novateurs annonce l\u2019investissement de 29,9 millions $<\/strong> afin de soutenir l\u2019\u00e9volution du secteur des produits pharmaceutiques<\/strong> et consolider sa place de chef de file dans le domaine des radio-isotopes m\u00e9dicaux<\/strong> au Canada et dans l'\u00e9cosyst\u00e8me des sciences de la vie du Qu\u00e9bec.\n\nDe cette somme, environ 19 millions $<\/strong> seront consacr\u00e9s \u00e0 l\u2019agrandissement et \u00e0 la modernisation du site de l\u2019arrondissement de Lachine et 11 millions $<\/strong> serviront \u00e0 l\u2019achat d\u2019\u00e9quipements de haute technologie dont un cyclotron de 18 MeV<\/strong> qui sera op\u00e9rationnel d\u00e8s le premier trimestre 2026<\/strong>. Cet investissement permettra de s\u00e9curiser la chaine d\u2019approvisionnement<\/strong> et r\u00e9pondre \u00e0 la demande croissante de radio-isotopes TEP<\/strong> (tomographie \u00e0 \u00e9mission de positrons) \u00e0 des fins diagnostiques au Qu\u00e9bec et au Canada.\n\nLisez le communiqu\u00e9 en entier ici https:\/\/www.newswire.ca\/fr\/news-releases\/investissement-majeur-de-29-9-millions-d-isologic-au-quebec-806446738.html<\/a><\/strong>","_et_gb_content_width":"","footnotes":""},"categories":[16,14,26,13],"tags":[],"class_list":["post-2999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dans-la-presse","category-in-the-press-2","category-isologic-news-3","category-nouvelles-isologic"],"_links":{"self":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/2999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/comments?post=2999"}],"version-history":[{"count":0,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/2999\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media\/3011"}],"wp:attachment":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media?parent=2999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/categories?post=2999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/tags?post=2999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}